Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid prophylaxis for postpartum hemorrhage in anemic women in South China
ChiCTR2200061044Phase 4Not yet recruiting
- Sponsor
- Guangzhou Women and Children's Medical Center
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in postpartum hemorrhage (PPH) and anaemia (2 arms), sponsored by Guangzhou Women and Children's Medical Center. Primary endpoint: Incidence of postpartum hemorrhage. Planned start May 2022; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)anaemia
Beyond the preview
Go deeper on ChiCTR2200061044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061044.